← Back to Clinical Trials
Recruiting NCT06639802

NCT06639802 Effects of Hand Arm Bimanual Intensive Therapy Including Lower Extremity on Balance and Coordination in Ataxic Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06639802
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Ataxic Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 23 participants
Start Date 2024-04-10
Primary Completion 2024-11-01

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Hand Arm Bimanual Intensive therapy including lower extremity (HABIT-ILE)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 23 participants in total. It began in 2024-04-10 with a primary completion date of 2024-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Ataxic cerebral palsy is an abnormal movement or posture pattern accompanied by a loss of coordinated muscle action, resulting in movements that lack proper force, rhythm, or accuracy. Ataxic CP is classified into cerebellar ataxia and ataxic diplegia. In Cerebellar Ataxia, the cerebellum is hypo-plastic or malformed which impairs the integration of brain signals required for coordinating coordinated movement and balance. This study aimed to determine the effect of HABIT-ILE on the balance and coordination of children with cerebellar ataxic cerebral palsy.

Eligibility Criteria

Inclusion Criteria: * Age group: 6 - 15 years. * Gender: Both males and females. * Cerebellar Ataxic cerebral palsy \[10\] * Gross motor function classification system level I and II. * Capable of following instructions and completing all necessary tests and tasks Exclusion Criteria: * Uncontrolled epilepsy * Orthopedic surgery within the past 6 months, * Have visual, and hearing impairments (diagnosed).

Contact & Investigator

Central Contact

Amina Aqil, MS-NPT

✉ aminaaqil11@gmail.com

📞 +923330418548

Frequently Asked Questions

Who can join the NCT06639802 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 15 Years, studying Ataxic Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06639802 currently recruiting?

Yes, NCT06639802 is actively recruiting participants. Contact the research team at aminaaqil11@gmail.com for enrollment information.

Where is the NCT06639802 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT06639802 clinical trial?

NCT06639802 is sponsored by Foundation University Islamabad. The trial plans to enroll 23 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology